NCT00128518View on ClinicalTrials.gov

IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs

PHASE4CompletedINTERVENTIONAL

Enrollment

139

Participants

Timeline

Start Date

October 31, 2004

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Hypertension

Interventions

DRUG

Indapamide (T2)

1.5 mg/day during 4 weeks

DRUG

Perindopril (T1)

4 mg/day during 1 week then 8 mg/day during 3 weeks

DRUG

Placebo of Perindopril (P1)

1 pill/day during 1 week then 2 pills/day during 3 weeks

DRUG

Placebo of Indapamide (P2)

1 pill/day during 4 weeks

Trial Locations (1)

69677

Hôpital Louis Pradel, Bron

All Listed Sponsors

lead

Hospices Civils de Lyon

OTHER

NCT00128518 - IDEAL Study: Identification of the Determinants of the Efficacy of Arterial Blood Pressure Lowering Drugs | Biotech Hunter | Biotech Hunter